Apotex Research Private Limited - Company Profile

It is a pharma private limited company based in Jigani Hobli, Karnataka, India, established in 2003.

2003 Jigani Hobli, Karnataka, India Active

Last Updated: January 05, 2026

About Apotex Research Private Limited

Apotex Research Private Limited, a active private limited company, was established on 16 June 2003 in Jigani Hobli, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U73100KA2003PTC032103. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹460.00 Cr and a paid-up capital of ₹291.86 Cr.

It upholds a compliant status. Employing 1,236 professional, Its leadership includes Brian George Mcclelland (Director), Rajesh Salwan (Additional Director), Goutam Vilas Pujari (Director). Past directors included Brian George Mcclelland, Robert Craig Baxter, Jeremy Bharat Desai. It holds ₹483.80 Cr open charges and no settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Site No.1,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Jigani Hobli, Karnataka, 562158.

Company Details

CIN/LLPIN
U73100KA2003PTC032103
Registration Number
032103
Incorporation Date
16 June 2003
Authorized Capital
₹460.00 Cr
Paid-Up Capital
₹291.86 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 460.00 Cr as on 05-01-2026
Paid Up Capital ₹ 291.86 Cr as on 05-01-2026
Company Age 22 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 483.80 Cr as on 05-01-2026
Revenue Growth **** 16.82% (FY 2023)
Profit Growth **** 109.79% (FY 2023)
Ebitda **** 24.96% (FY 2023)
Net Worth -0.42% (FY 2023)
Total Assets -4.46% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Apotex Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Apotex Research Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Brian George Mcclelland	Director	15 Sep 2023	Current
Rajesh Salwan	Additional Director	18 Mar 2025	Current
Goutam Vilas Pujari	Director	01 Dec 2018	Current
Uta Kellermann Renton	Additional Director	18 Mar 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	21 Sep 2023	Past
Pramod Abcsdd	Director	16 Jan 2015	Past
Pramod Abcsdd	Director	08 May 2018	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Additional Director	23 Sep 2024	Past
Pramod Abcsdd	Additional Director	30 Sep 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apotex Research.

Apotex Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.82% increase. The company also saw a substantial improvement in profitability, with a 109.79% increase in profit. The company's net worth dipped by a decrease of 0.42%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

16.82%

*******

Revenue from Operations

*******

13.28%

*******

Total Assets

*******

-4.46%

*******

Profit or Loss

*******

109.79%

*******

Net Worth

*******

-0.42%

*******

EBITDA

*******

24.96%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apotex Research?

In 2023, Apotex Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹4,838,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Apotex Pharmaceutical Holdings Inc : 250.00 Cr
The Hongkong And Shanghai Banking Corporation Limited : 198.80 Cr
Others : 35.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Sep 2023	Others	₹30.00 Cr	Open
09 Jun 2017	Others	₹5.00 Cr	Open
24 Mar 2016	The Hongkong And Shanghai Banking Corporation Limited	₹8.00 M	Open
17 Oct 2012	The Hongkong And Shanghai Banking Corporation Limited	₹198.00 Cr	Open
31 Mar 2006	Apotex Pharmaceutical Holdings Inc	₹250.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Apotex Research?

Apotex Research has a workforce of 1236 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Apotex Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apotex Research's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apotex Research

Recent Activity within the Organization

Director Appointment

The activity Shama Shridhar Doddawad was appointed as a Cfo was appointed as a Cfo on 18 Apr 2025 & has been associated with this company since 11 months 30 days . was completed.
18 Apr 2025
Director Appointment

Progress on Rajesh Salwan was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2025 & has been associated with this company since 1 year 30 days . was documented.
18 Mar 2025
Director Appointment

Progress on Uta Kellermann Renton was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2025 & has been associated with this company since 1 year 30 days . was documented.
18 Mar 2025
Annual General Meeting

The activity Apotex Research Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was completed.
24 Sep 2024
Balance Sheet

The activity Apotex Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
31 Mar 2024
Charges

A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100801520 was registered on 30 Sep 2023. was recorded as a recent event.
30 Sep 2023

Explore recent activity and updates - View Recent Activity